Zai Lab appoints Scott Morrison to board of directors and audit committee

Zai Lab Ltd

Scott Morrison appointed as independent director and Audit Committee member effective October 13, 2021.
Receives annual retainer of $50,000 board plus $10,000 audit, pro-rated to $13,200 for 2021; initial grant of 7,345 restricted ordinary shares.
Morrison was Ernst & Young US Life Sciences Leader (2002-2015); currently serves on boards of Corvus, GBT, IDEAYA, Vera Therapeutics.
No arrangements or transactions requiring Item 404(a) disclosure; no other understanding for selection as director.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Scott W. Morrison

independent director

ZLAB · Zai Lab Ltd

Effective: 2021-10-13
Filed: October 18, 2021, 7:59 PM ET

On October 13, 2021 (U.S. Eastern Time), the Board of Directors (the “Board”) of Zai Lab Limited (the “Company”) appointed Scott W. Morrison as an independent director, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Scott W. Morrison was appointed as independent director at Zai Lab Ltd.

Action: appointed
Role: independent director

Exact text from the filing

On October 13, 2021 (U.S. Eastern Time), the Board of Directors (the “Board”) of Zai Lab Limited (the “Company”) appointed Scott W. Morrison as an independent director, effective immediately.

View on SEC.gov

Zai Lab Ltd filing history →

Source: SEC EDGAR

accession 0001193125-21-300554

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.